Vitamin K antagonists
Sponsors
University Medical Center Groningen, Boehringer Ingelheim, Bayer
Conditions
Atrial FibrillationAtrial Fibrillation (Prevention of Stroke)NeoplasmsVenous Thromboembolism
Phase 3
Unknown Phase
Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)
CompletedNCT02240667
Start: 2014-09-18End: 2017-12-31Updated: 2019-04-19
Real-Life Evidence on Stroke Prevention in SPAF
CompletedNCT02485873
Start: 2015-05-31End: 2015-09-30Updated: 2015-11-11
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
CompletedNCT02864758
Start: 2016-09-08End: 2018-09-30Updated: 2023-11-07